Cargando…

Drug and xenobiotic biotransformation in the blood–brain barrier: a neglected issue

Drug biotransformation is a crucial mechanism for facilitating the elimination of chemicals from the organism and for decreasing their pharmacological activity. Published evidence suggests that brain drug metabolism may play a role in the development of adverse drug reactions and in the clinical res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agúndez, José A. G., Jiménez-Jiménez, Félix J., Alonso-Navarro, Hortensia, García-Martín, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201098/ https://www.ncbi.nlm.nih.gov/pubmed/25368552 http://dx.doi.org/10.3389/fncel.2014.00335

Ejemplares similares

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
por: Jiménez-Jiménez, Félix J., et al.
Publicado: (2014)

The Transformer database: biotransformation of xenobiotics
por: Hoffmann, Michael F., et al.
Publicado: (2014)

Biotransformation of xenobiotics in human intestinal mucosa
por: Hoensch, H. P., et al.
Publicado: (1979)

An association study between Heme oxygenase-1 genetic variants and Parkinson's disease
por: Ayuso, Pedro, et al.
Publicado: (2014)

Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
por: Martínez, Carmen, et al.
Publicado: (2010)

The Relationship Between Parkinson's Disease and Essential Tremor: Review of Clinical, Epidemiologic, Genetic, Neuroimaging and Neuropathological Data, and Data on the Presence of Cardinal Signs of Parkinsonism in Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2012)

Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2016)

Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
por: Alonso-Navarro, Hortensia, et al.
Publicado: (2020)

Current Treatment Options for REM Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Neurochemical Features of Rem Sleep Behaviour Disorder
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19?
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2020)

Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Sleep Disorders and Sleep Problems in Patients With Tourette Syndrome and Other Tic Disorders: Current Perspectives
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2022)

Coenzyme Q10 and Dementia: A Systematic Review
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Missense Gamma-Aminobutyric Acid Receptor Polymorphisms Are Associated with Reaction Time, Motor Time, and Ethanol Effects in Vivo
por: García-Martín, Elena, et al.
Publicado: (2018)

The CYPome of the model xenobiotic-biotransforming fungus Cunninghamella elegans
por: Palmer-Brown, William, et al.
Publicado: (2019)

Genomic Markers for Essential Tremor
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2021)

Relationship between biotransformation and the toxicity and fate of xenobiotic chemicals in fish.
por: Lech, J J, et al.
Publicado: (1980)

Prediction of reacting atoms for the major biotransformation reactions of organic xenobiotics
por: Rudik, Anastasia V., et al.
Publicado: (2016)

Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2023)

Biotransformation and induction: implications for toxicity, bioaccumulation and monitoring of environmental xenobiotics in fish.
por: Kleinow, K M, et al.
Publicado: (1987)

Editorial on Cerebral endothelial and glial cells are more than bricks in the Great Wall of the brain: insights into the way the blood-brain barrier actually works (celebrating the centenary of Goldman's experiments)
por: García-Martín, Elena, et al.
Publicado: (2015)

A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota
por: Sharma, Ashok K., et al.
Publicado: (2017)

GLORYx: Prediction of the Metabolites Resulting from Phase 1 and Phase 2 Biotransformations of Xenobiotics
por: de Bruyn Kops, Christina, et al.
Publicado: (2020)

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
por: Agúndez, José A. G., et al.
Publicado: (2012)

Special Issue “Microbial Biodegradation and Biotransformation”
por: Ivshina, Irina, et al.
Publicado: (2023)

Polymorphisms in DNA Repair and Xenobiotic Biotransformation Enzyme Genes and Lung Cancer Risk in Coal Mine Workers
por: Minina, Varvara, et al.
Publicado: (2022)

Pharmacophore Modeling Using Machine Learning for Screening the Blood–Brain Barrier Permeation of Xenobiotics
por: Kumar, Saurav, et al.
Publicado: (2022)

Functional polymorphisms of xenobiotics metabolizing enzymes—a research topic
por: Agúndez, José A. G., et al.
Publicado: (2013)

Sex Differences in Blood–Brain Barrier Transport of Psychotropic Drugs
por: Dalla, Christina, et al.
Publicado: (2022)

Biotransformation modulates the penetration of metallic nanomaterials across an artificial blood–brain barrier model
por: Guo, Zhiling, et al.
Publicado: (2021)

Hereditary Coproporphyria Associated with the Q306X Mutation in the Coproporphyrin Oxidase Gene Presenting with Acute Ataxia
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2013)

Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood–brain barrier model
por: Ghosh, Chaitali, et al.
Publicado: (2018)

Special Issue: Microbial Degradation of Xenobiotics
por: Nagata, Yuji
Publicado: (2020)

Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain
por: Hernández-Parra, Héctor, et al.
Publicado: (2023)

The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication
por: Ouzzine, Mohamed, et al.
Publicado: (2014)

Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview
por: Pimentel, Emely, et al.
Publicado: (2020)

Atlantic Salmon Gill Epithelial Cell Line (ASG-10) as a Suitable Model for Xenobiotic Biotransformation
por: Ivanova, Lada, et al.
Publicado: (2023)

Brain Waste: The Neglect of Animal Brains
por: Cozzi, Bruno, et al.
Publicado: (2020)

The impact of microglial activation on blood-brain barrier in brain diseases
por: da Fonseca, Anna Carolina Carvalho, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c36fjkh1rg5r6b717hlhobgb8v